Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis.
作者信息
Solomon Daniel H, Peters Mike J L, Nurmohamed Michael T, Dixon Will
机构信息
Harvard Medical School, Boston, MA, USA.
出版信息
Arthritis Rheum. 2013 Jul;65(7):1675-83. doi: 10.1002/art.37975.
Abstract
摘要
相似文献
1
Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis.
Arthritis Rheum. 2013 Jul;65(7):1675-83. doi: 10.1002/art.37975.
2
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
J Rheumatol. 2015 Oct;42(10):1767-80. doi: 10.3899/jrheum.141112. Epub 2015 Jul 15.
3
Cardiovascular risk estimation and management in rheumatoid arthritis: comment on the EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 87):S-16-7. Epub 2014 Oct 22.
4
Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice.
Ann Rheum Dis. 2014 Jul;73(7):1284-8. doi: 10.1136/annrheumdis-2013-204792. Epub 2014 Mar 7.
5
Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.
Curr Rheumatol Rep. 2017 Apr;19(4):16. doi: 10.1007/s11926-017-0643-y.
6
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis.
Joint Bone Spine. 2024 Dec;91(6):105790. doi: 10.1016/j.jbspin.2024.105790. Epub 2024 Oct 9.
7
[Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first].
Ned Tijdschr Geneeskd. 2011;155(29):A3563.
8
When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.
Arthritis Care Res (Hoboken). 2016 Jan;68(1):26-35. doi: 10.1002/acr.22758. Epub 2015 Nov 6.
9
Rheumatoid arthritis and glucocorticoids; the contribution of a literature search to the development of a EULAR recommendation on treatment with glucocorticoids in RA.
Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S77-80. Epub 2011 Oct 21.
10
APLAR rheumatoid arthritis treatment recommendations.
Int J Rheum Dis. 2015 Sep;18(7):685-713. doi: 10.1111/1756-185X.12754.
引用本文的文献
1
Extensive triple vessel coronary artery disease in a young male with juvenile idiopathic arthritis.
Oxf Med Case Reports. 2021 Dec 28;2021(11-12):omab119. doi: 10.1093/omcr/omab119. eCollection 2021 Nov-Dec.
2
The Relationship of Three-Dimensional Joint Space Width on Weight Bearing CT With Pain and Physical Function.
J Orthop Res. 2019 Dec 16. doi: 10.1002/jor.24566.
3
Systems Biology and Noninvasive Imaging of Atherosclerosis.
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):e1-8. doi: 10.1161/ATVBAHA.115.306350.
4
Selection bias in rheumatic disease research.
Nat Rev Rheumatol. 2014 Jul;10(7):403-12. doi: 10.1038/nrrheum.2014.36. Epub 2014 Apr 1.
5
Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.
Heart Fail Clin. 2014 Apr;10(2):339-52. doi: 10.1016/j.hfc.2013.10.003. Epub 2014 Jan 10.
6
The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.
Clin Rheumatol. 2014 Jun;33(6):769-74. doi: 10.1007/s10067-014-2522-5. Epub 2014 Feb 15.
7
Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic.
Rheumatol Int. 2014 Jan;34(1):93-9. doi: 10.1007/s00296-013-2851-8. Epub 2013 Sep 5.
本文引用的文献
1
Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis.
Arthritis Res Ther. 2012 Dec 13;14(6):R270. doi: 10.1186/ar4118.
2
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.
Arthritis Rheum. 2012 Sep;64(9):2836-46. doi: 10.1002/art.34524.
3
Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.
Am J Cardiol. 2012 Aug 1;110(3):420-4. doi: 10.1016/j.amjcard.2012.03.044. Epub 2012 Apr 20.
4
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.
Ann Rheum Dis. 2012 Sep;71(9):1524-9. doi: 10.1136/annrheumdis-2011-200726. Epub 2012 Mar 16.
5
Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis.
Semin Arthritis Rheum. 2012 Feb;41(4):535-44. doi: 10.1016/j.semarthrit.2011.07.004.
6
Pragmatic randomised trials using routine electronic health records: putting them to the test.
BMJ. 2012 Feb 7;344:e55. doi: 10.1136/bmj.e55.
7
Paradoxical and bidirectional drug effects.
Drug Saf. 2012 Mar 1;35(3):173-89. doi: 10.2165/11597710-000000000-00000.
8
Risk factors for cardiovascular disease in rheumatoid arthritis.
Curr Opin Rheumatol. 2012 Mar;24(2):171-6. doi: 10.1097/BOR.0b013e32834ff2fd.
9
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
Ann Rheum Dis. 2012 Jun;71(6):869-74. doi: 10.1136/annrheumdis-2011-200622. Epub 2012 Jan 12.
10
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
Arthritis Rheum. 2012 Jan;64(1):42-52. doi: 10.1002/art.30654.
Zotero 插件